Moelis & Company (NYSE:MC - Free Report) - Analysts at Seaport Res Ptn dropped their Q2 2025 earnings estimates for Moelis & Company in a research report issued on Wednesday, April 9th. Seaport Res Ptn analyst J. Mitchell now anticipates that the asset manager will post earnings per share of $0.23 for the quarter, down from their previous estimate of $0.55. The consensus estimate for Moelis & Company's current full-year earnings is $2.97 per share. Seaport Res Ptn also issued estimates for Moelis & Company's Q3 2025 earnings at $0.34 EPS, Q4 2025 earnings at $0.81 EPS, FY2025 earnings at $2.00 EPS, Q1 2026 earnings at $0.58 EPS, Q2 2026 earnings at $0.57 EPS, Q3 2026 earnings at $0.68 EPS and FY2026 earnings at $3.15 EPS.
Several other brokerages have also weighed in on MC. Wells Fargo & Company lowered their target price on shares of Moelis & Company from $63.00 to $55.00 and set an "equal weight" rating for the company in a research note on Tuesday, April 8th. The Goldman Sachs Group cut their target price on Moelis & Company from $86.00 to $75.00 and set a "neutral" rating on the stock in a research report on Friday, March 14th. Keefe, Bruyette & Woods restated an "outperform" rating and set a $92.00 price target (up from $86.00) on shares of Moelis & Company in a research report on Thursday, February 6th. Morgan Stanley cut their price objective on Moelis & Company from $70.00 to $42.00 and set an "underweight" rating on the stock in a report on Monday, April 7th. Finally, StockNews.com cut Moelis & Company from a "buy" rating to a "hold" rating in a report on Thursday, March 13th. Two equities research analysts have rated the stock with a sell rating, five have given a hold rating and one has issued a buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of "Hold" and an average price target of $62.50.
Read Our Latest Stock Analysis on MC
Moelis & Company Trading Up 0.4 %
Moelis & Company stock traded up $0.22 during mid-day trading on Friday, hitting $52.34. The company's stock had a trading volume of 696,772 shares, compared to its average volume of 724,085. The stock's fifty day moving average is $63.69 and its two-hundred day moving average is $70.02. The firm has a market capitalization of $3.92 billion, a PE ratio of 29.74 and a beta of 1.53. Moelis & Company has a 1 year low of $46.24 and a 1 year high of $82.89.
Moelis & Company (NYSE:MC - Get Free Report) last posted its earnings results on Wednesday, February 5th. The asset manager reported $1.18 earnings per share for the quarter, beating the consensus estimate of $0.39 by $0.79. Moelis & Company had a net margin of 11.39% and a return on equity of 38.49%.
Moelis & Company Increases Dividend
The business also recently announced a quarterly dividend, which was paid on Thursday, March 27th. Investors of record on Tuesday, February 18th were paid a dividend of $0.65 per share. This represents a $2.60 annualized dividend and a yield of 4.97%. This is a boost from Moelis & Company's previous quarterly dividend of $0.60. The ex-dividend date was Tuesday, February 18th. Moelis & Company's payout ratio is presently 147.73%.
Insiders Place Their Bets
In related news, CEO Kenneth Moelis sold 9,712 shares of the stock in a transaction on Wednesday, February 19th. The stock was sold at an average price of $74.00, for a total value of $718,688.00. Following the transaction, the chief executive officer now owns 209,235 shares of the company's stock, valued at $15,483,390. This represents a 4.44 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, insider Christopher Callesano sold 1,282 shares of Moelis & Company stock in a transaction dated Wednesday, February 19th. The stock was sold at an average price of $74.00, for a total value of $94,868.00. Following the sale, the insider now directly owns 1,227 shares of the company's stock, valued at $90,798. This trade represents a 51.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 22,721 shares of company stock worth $1,677,017 in the last quarter. 6.40% of the stock is owned by company insiders.
Institutional Investors Weigh In On Moelis & Company
Several hedge funds and other institutional investors have recently made changes to their positions in MC. Madison Investment Advisors LLC purchased a new position in Moelis & Company in the fourth quarter valued at approximately $86,062,000. Norges Bank acquired a new position in shares of Moelis & Company in the 4th quarter valued at $52,610,000. Balyasny Asset Management L.P. grew its position in shares of Moelis & Company by 215.5% in the 4th quarter. Balyasny Asset Management L.P. now owns 723,384 shares of the asset manager's stock valued at $53,444,000 after buying an additional 494,123 shares during the last quarter. Raymond James Financial Inc. acquired a new stake in Moelis & Company during the 4th quarter worth $27,855,000. Finally, Capital Research Global Investors purchased a new stake in Moelis & Company in the fourth quarter valued at $20,720,000. Institutional investors and hedge funds own 91.53% of the company's stock.
Moelis & Company Company Profile
(
Get Free Report)
Moelis & Co operates as a holding company. It engages in the provision of financial advisory, capital raising and asset management services to a client base including corporations, governments, sovereign wealth funds and financial sponsors. The firm focuses on clients including large public multinational corporations, middle market private companies, financial sponsors, entrepreneurs and governments.
Featured Stories

Before you consider Moelis & Company, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Moelis & Company wasn't on the list.
While Moelis & Company currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.